Thousands of lung health experts, including researchers, scientists, health professionals, doctors, civil society, affected communities, government officials, nurses and students from around the world will attend #UnionConf2024, and we hope you will be one of them.

We look forward to sharing knowledge and learning from each other at this Conference where EVERYONE comes together, as we strive for a healthier world for all, free from Tuberculosis and lung diseases.

Dr. Alland is a Professor of Medicine and the Chief of Infectious Disease as well as the Director of the Center for Emerging Pathogens and the Rutgers Regional Biocontainment Laboratories at Rutgers New Jersey Medical School. Dr. Alland is internationally recognized for his pioneering work on the epidemiology, diagnosis, treatment, and molecular evolution of M. tuberculosis (Mtb).

TBS-EP-66: Optimal processing of tongue swab samples for M. tuberculosis detection by the Xpert MTB/RIF Ultra assay 

Thursday, November 14, 1:35 – 1:40 PM. Room: Mangupura E-Posters 7. Held during the TBScience E-Poster Session: TBS-EP03 Fundamental advances in understanding pathogenesis | Part 1 (Nov 14, 12:15 – 2:15 PM)

Nathan is a DPhil student at the University of Oxford studying Paediatrics on a Marshall Scholarship. He is a recent graduate of Johns Hopkins University with a BS and MS in Molecular and Cellular Biology, where his thesis work centered around the production of melanin in the fungus Candida auris. At Oxford, Nathan studies novel technologies for the diagnosis of paediatric TB as part of the NIH-funded FEND for TB consortium.

0A39-410-15: Oral swab testing for the diagnosis of paediatric TB: An interim analysis of diagnostic accuracy in the NOD-pedFEND cohort

Friday, November 15, 2:34 – 2:43 PM. Room: Frangipani. Held during the C3: Maternal and child TB, Oral Abstract Session: 0A39 Optimising finding TB in children (Nov 15, 2:20 – 3:50 PM)

Dr. Alland is a Professor of Medicine and the Chief of Infectious Disease as well as the Director of the Center for Emerging Pathogens and the Rutgers Regional Biocontainment Laboratories at Rutgers New Jersey Medical School. Dr. Alland is internationally recognized for his pioneering work on the epidemiology, diagnosis, treatment, and molecular evolution of M. tuberculosis (Mtb).

LB04-1227-15: A cartridge-based assay for improved detection of multi-drug-resistant M. tuberculosis directly from sputum 

Friday, November 15, 5:00 – 5:09 PM. Room: Mangupura. Held during the Oral Abstract Session: LB04 The Union-CDC late-breaker session (epidemiology and programmatic) (Nov 15, 4:10 – 5:40 PM)